4//SEC Filing
HILL NANCY LOUISE 4
Accession 0001209191-21-004769
CIK 0001478320other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 9:00 PM ET
Size
15.0 KB
Accession
0001209191-21-004769
Insider Transaction Report
Form 4
HILL NANCY LOUISE
Sr Vice President, Operations
Transactions
- Sale
Common Stock
2021-01-19$69.00/sh−25,000$1,725,000→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-19−23,000→ 27,000 totalExercise: $4.07Exp: 2025-04-17→ Common Stock (23,000 underlying) - Exercise/Conversion
Common Stock
2021-01-19$0.84/sh+2,000$1,680→ 12,000 total - Exercise/Conversion
Common Stock
2021-01-19$4.07/sh−23,000$93,610→ 35,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-19−2,000→ 0 totalExercise: $0.84Exp: 2023-11-03→ Common Stock (2,000 underlying)
Holdings
- 500(indirect: By Ryan Hill (son))
Common Stock
- 300(indirect: By Connor Hill (son))
Common Stock
- 400(indirect: By Brandon Hill (son))
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780790
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 9:00 PM ET
- Size
- 15.0 KB